NVST logo

Envista Holdings Corporation (NVST)

$21.97

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on NVST

Market cap

$3.61B

EPS

0.09

P/E ratio

246

Price to sales

1.39

Dividend yield

--

Beta

1.02623

Price on NVST

Previous close

$22.14

Today's open

$22.18

Day's range

$21.76 - $22.30

52 week range

$14.22 - $22.68

Profile about NVST

CEO

Paul Keel

Employees

12300

Headquarters

Brea, CA

Exchange

New York Stock Exchange

Shares outstanding

164426233

Issue type

Common Stock

NVST industries and sectors

Healthcare

Medical Equipment & Supplies

News on NVST

Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript

Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript

news source

Seeking Alpha • Dec 3, 2025

news preview

Here's Why Envista (NVST) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Nov 28, 2025

news preview

Envista Announces Participation in 8th Annual Evercore Healthcare Conference

BREA, Calif. , Nov. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 8th Annual Evercore Healthcare Conference.

news source

PRNewsWire • Nov 25, 2025

news preview

Envista Holdings Corporation (NVST) Q3 2025 Earnings Call Transcript

Envista Holdings Corporation ( NVST ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Jim Gustafson - Vice President of Investor Relations Paul Keel - CEO & Director Eric Hammes - Senior VP & CFO Conference Call Participants Allen Lutz - BofA Securities, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Linda Bolduc - Morgan Stanley, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Russell Yuen - William Blair & Company L.L.C.

news source

Seeking Alpha • Oct 31, 2025

news preview

Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Oct 31, 2025

news preview

Envista Reports Third Quarter 2025 Results

BREA, Calif. , Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025.

news source

PRNewsWire • Oct 30, 2025

news preview

Envista Announces Release of 2024 Sustainability Report

BREA, Calif. , Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2024 Sustainability Report, highlighting ongoing efforts to pursue progress with purpose as it integrates sustainable and responsible business practices to achieve its mission of partnering with professionals to improve lives.

news source

PRNewsWire • Oct 29, 2025

news preview

Envista (NVST) Earnings Expected to Grow: Should You Buy?

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Oct 23, 2025

news preview

Will Envista (NVST) Beat Estimates Again in Its Next Earnings Report?

Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

news source

Zacks Investment Research • Oct 20, 2025

news preview

NVST or ABT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two stocks is more attractive to value investors?

news source

Zacks Investment Research • Oct 15, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Envista Holdings Corporation

Open an M1 investment account to buy and sell Envista Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in NVST on M1